• Thu, April 2, 2020

by: WOPRAI

Simon Yarmak Maintained (VICI) at Strong Buy with Decreased Target to $25 on, Apr 2nd, 2020

by: WOPRAI

Thomas Diffely Downgraded (ACLS) to Hold on, Apr 2nd, 2020

by: WOPRAI

Simeon Gutman Maintained (AAP) at Buy with Decreased Target to $135 on, Apr 2nd, 2020

by: WOPRAI

Matt O"Connor Maintained (BAC) at Hold with Increased Target to $27 on, Apr 2nd, 2020

by: WOPRAI

Casey Alexander Downgraded (BBDC) to Hold and Held Target at $8.5 on, Apr 2nd, 2020

by: WOPRAI

Gerrick Johnson Downgraded (BC) to Hold and Decreased Target to $34 on, Apr 2nd, 2020

by: WOPRAI

Debbie Jones Maintained (AMCR) at Strong Buy with Increased Target to $9.25 on, Apr 2nd, 2020

by: WOPRAI

Thomas Diffely Downgraded (AMAT) to Hold on, Apr 2nd, 2020

by: WOPRAI

Richard Skidmore Downgraded (AMH) to Hold and Held Target at $24 on, Apr 2nd, 2020

by: WOPRAI

Spiro Dounis Downgraded (ALTM) to Sell and Decreased Target to $10 on, Apr 2nd, 2020

by: WOPRAI

Ann Duignan Maintained (ALSN) at Sell with Decreased Target to $90 on, Apr 2nd, 2020

by: WOPRAI

Casey Alexander Upgraded (ARCC) to Strong Buy on, Apr 2nd, 2020

by: WOPRAI

Itay Michaeli Initiated (APTV) at Strong Buy and Held Target at $67 on, Apr 2nd, 2020

by: WOPRAI

Wamsi Mohan Reiterated (APH) at Strong Buy with Decreased Target to $24 on, Apr 2nd, 2020

by: WOPRAI

Todd Stender Maintained (ADC) at Buy with Decreased Target to $67 on, Apr 2nd, 2020

by: WOPRAI

Ryan Levine Maintained (AEP) at Hold with Decreased Target to $82 on, Apr 2nd, 2020

by: WOPRAI

Shelby Tucker Upgraded (AES) to Buy and Decreased Target to $18 on, Apr 2nd, 2020

by: WOPRAI

Pauline Bell Reiterated (USB) at Strong Buy with Decreased Target to $40 on, Apr 2nd, 2020

by: WOPRAI

Matt O"Connor Maintained (USB) at Hold with Decreased Target to $42 on, Apr 2nd, 2020

by: WOPRAI

Batya Levi Upgraded (AMT) to Strong Buy and Held Target at $270 on, Apr 2nd, 2020

by: WOPRAI

David Risinger Maintained (AMRX) at Hold with Decreased Target to $3 on, Apr 2nd, 2020

by: WOPRAI

David Risinger Maintained (ALKS) at Hold with Decreased Target to $16 on, Apr 2nd, 2020

by: WOPRAI

Michael Lewis Maintained (AIV) at Hold with Decreased Target to $53 on, Apr 2nd, 2020

by: WOPRAI

Nicole Miller Regan Maintained (CAKE) at Buy with Decreased Target to $26 on, Apr 2nd, 2020

by: WOPRAI

Ed Caso Maintained (CACI) at Buy with Decreased Target to $280 on, Apr 2nd, 2020

by: WOPRAI

Michael Lavery Maintained (BYND) at Hold with Decreased Target to $72 on, Apr 2nd, 2020

by: WOPRAI

Matthew O"Connor Maintained (C) at Hold with Decreased Target to $61 on, Apr 2nd, 2020

by: WOPRAI

Alex Zukin Maintained (ZM) at Hold with Increased Target to $125 on, Apr 2nd, 2020

by: WOPRAI

Daniel Arias Maintained (A) at Hold with Decreased Target to $73 on, Apr 2nd, 2020

by: WOPRAI

David Risinger Maintained (ZTS) at Hold with Decreased Target to $125 on, Apr 2nd, 2020

by: WOPRAI

John McNulty Maintained (AXTA) at Buy with Decreased Target to $28 on, Apr 2nd, 2020

by: WOPRAI

Rob Oliver Downgraded (AZPN) to Hold and Decreased Target to $100 on, Apr 2nd, 2020

by: WOPRAI

Simeon Gutman Maintained (AZO) at Buy on, Apr 2nd, 2020

by: WOPRAI

Joseph DeNardi Downgraded (BAH) to Hold and Decreased Target to $85 on, Apr 2nd, 2020

by: WOPRAI

Ed Caso Maintained (BAH) at Buy with Decreased Target to $77 on, Apr 2nd, 2020

by: WOPRAI

Todd Stender Maintained (WPC) at Buy with Decreased Target to $64 on, Apr 2nd, 2020

by: WOPRAI

Daniel Arias Maintained (TECH) at Strong Buy with Decreased Target to $53 on, Apr 2nd, 2020

by: WOPRAI

Peter Arment Maintained (TDG) at Hold with Decreased Target to $366 on, Apr 2nd, 2020

by: WOPRAI

George Hill Maintained (TDOC) at Strong Buy with Decreased Target to $179 on, Apr 2nd, 2020

by: WOPRAI

Tyler Radke Upgraded (TDC) to Strong Buy and Increased Target to $28 on, Apr 2nd, 2020

by: WOPRAI

David Risinger Maintained (TEVA) at Sell with Decreased Target to $8 on, Apr 2nd, 2020

by: WOPRAI

Wamsi Mohan Reiterated (TEL) at Strong Buy with Decreased Target to $88 on, Apr 2nd, 2020

by: WOPRAI

Sarah Akers Maintained (CNP) at Hold with Decreased Target to $17 on, Apr 2nd, 2020

by: WOPRAI

Andrea Pistacchi Maintained (CCEP) at Strong Buy with Decreased Target to $51 on, Apr 2nd, 2020

by: WOPRAI

Jason Kupferberg Upgraded (WU) to Strong Buy on, Apr 2nd, 2020

by: WOPRAI

Andrew Jeffrey Maintained (WU) at Hold with Decreased Target to $18 on, Apr 2nd, 2020

by: WOPRAI

Steve Beuchaw Upgraded (XRAY) to Buy and Held Target at $66 on, Apr 2nd, 2020

by: WOPRAI

Paul Coster Maintained (XRX) at Hold with Decreased Target to $25 on, Apr 2nd, 2020

David Risinger Maintained (AMRX) at Hold with Decreased Target to $3 on, Apr 2nd, 2020

David Risinger of Morgan Stanley, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $5 to $3 on, Apr 2nd, 2020.

David has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Randall Stanicky of "RBC Capital" Maintained at Hold with Increased Target to $4 on, Thursday, January 2nd, 2020